Natera (NTRA) Other Accumulated Expenses (2015 - 2026)
Natera's (NTRA) quarterly Other Accumulated Expenses came in at $228.5 million in Q2 2026, up 19.59% on a YoY basis from $191.0 million in Q2 2025, and up 7.49% quarter-over-quarter from $212.5 million in Q1 2026.
Analysis
Natera (NTRA) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
Natera (NTRA) has reported Other Accumulated Expenses for 11 consecutive years, with $228.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Accumulated Expenses rose 19.59% year-over-year to $228.5 million; the trailing twelve-month figure through Jun 2026 stood at $228.5 million (up 19.59% YoY), and the FY2025 full-year result was $188.7 million, up 28.43% from the prior year.
- Other Accumulated Expenses improved to $228.5 million in Q2 2026 per NTRA's latest filing, from $212.5 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $228.5 million in Q2 2026 and bottomed at $116.6 million in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $156.5 million across 5 years, with a median of $143.2 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses decreased 5.66% in 2024, then surged 71.15% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $144.2 million in 2022, then climbed by 3.6% to $149.4 million in 2023, then declined by 1.68% to $146.9 million in 2024, then increased by 28.43% to $188.7 million in 2025, then advanced by 21.09% to $228.5 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $228.5 million, $212.5 million, and $188.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 228.46 Mn |
| Mar 31, 2026 | 212.54 Mn |
| Dec 31, 2025 | 188.66 Mn |
| Sep 30, 2025 | 215.95 Mn |
| Jun 30, 2025 | 191.03 Mn |
| Mar 31, 2025 | 178.45 Mn |
| Dec 31, 2024 | 146.89 Mn |
| Sep 30, 2024 | 126.18 Mn |
| Jun 30, 2024 | 141.23 Mn |
| Mar 31, 2024 | 142.23 Mn |
| Dec 31, 2023 | 149.41 Mn |
| Sep 30, 2023 | 133.74 Mn |
| Jun 30, 2023 | 125.51 Mn |
| Mar 31, 2023 | 118.64 Mn |
| Dec 31, 2022 | 144.21 Mn |
| Sep 30, 2022 | 132.75 Mn |
| Jun 30, 2022 | 124.37 Mn |
| Mar 31, 2022 | 116.64 Mn |
| Dec 31, 2021 | 93.35 Mn |
| Dec 31, 2020 | 60.41 Mn |